June 2, 2005

FOR RELEASE:  Immediately

CTS EMS Receives Medical Design Excellence Award

Elkhart, IN…CTS Corporation (NYSE:CTS), a leading provider of electronics manufacturing services, announced today that it has been awarded the 2005 Medical Design Excellence Award for the SAGE Oxygen Therapeutics Device.

CTS manufactures this device for Chad Therapeutics, a supplier of oxygen delivery systems for home health care and hospital treatment. The SAGE Oxygen Therapeutics Device senses a patient’s movement and adjusts the rate of oxygen delivery to reduce the risk of oxygen desaturation as activity increases. This is the second medical design award in two years for CTS.

“The Medical Design Excellence Award is a testament to CTS’ engineering, supply-chain and project management capabilities. CTS’ goal is to create a competitive advantage for our customers, helping them bring quality products to market faster,” commented Don Schroeder, President of CTS Electronics Manufacturing Solutions.

Medical Design Excellence Award

The Medical Design Excellence Awards competition is sponsored by Canon Communications LLC and is the only awards program that exclusively recognizes contributions and advances in the design of medical products. Entries are evaluated on design and engineering features. These features include innovative use of materials and user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so the product meets its clinical objectives.

The 2005 Medical Design Excellence Award Winners will be honored at a ceremony during the Medical Design & Manufacturing (MD&M) East Conference and Exposition, June 13 – 15, 2005 at New York City’s Jacob K. Javits Convention Center.

About CTS Electronics Manufacturing Solutions

CTS’ EMS business offers core expertise in supporting the needs of medical customers. Key capabilities include design services, high-reliability surface mount assembly for high complexity electronics, fully integrated boxbuild systems, global support for clinical trials and cleanroom manufacturing. Manufacturing operations are located in North America, Europe and Asia.

For more information on CTS’ medical and related products, please contact Bob Miller at (805) 532-2800 (North America) and Sarah Hughes at 011-44-1698-505003 (Europe).

#  #  #  #

About CTS

CTS is a leading designer and manufacturer of electronic components and sensors and a provider of electronics manufacturing services (EMS) to OEMs in the automotive, computer and communications markets.  CTS manufactures products in North America, Europe and Asia. CTS' stock is traded on the NYSE under the ticker symbol "CTS." 

Safe Harbor Statement

This press release contains certain statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include, but are not limited to, statements regarding the business and strategic benefits of the SMTEK acquisition, any financial or other guidance, and all statements that are not based on historical fact, but rather reflect our current expectations concerning future results and events.  We make certain assumptions when making forward-looking statements, any of which could prove inaccurate, including, but not limited to, statements about our future operating results and business plans.  The ultimate correctness of these forward-looking statements is dependent upon a number of known and unknown risks and events, and is subject to various uncertainties and other factors that may cause our actual results, performance, or achievements to be different from any future results, performance, or achievements expressed or implied by these statements.

For more detailed information on the risks and uncertainties associated with CTS' business activities, see our reports filed with the SEC.  CTS undertakes no obligation to publicly update its forward-looking statements, whether as a result of market or industry changes, new information or future events.